DSS Stock Overview
DSS, Inc. operates in the product packaging, biotechnology, direct, commercial lending, securities and investment management, alternative trading, digital transformation, secure living, and alternative energy businesses worldwide.
DSS, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$0.28|
|52 Week High||US$1.30|
|52 Week Low||US$0.25|
|1 Month Change||-22.97%|
|3 Month Change||-19.21%|
|1 Year Change||-76.50%|
|3 Year Change||-97.64%|
|5 Year Change||-98.91%|
|Change since IPO||-99.97%|
Recent News & Updates
|DSS||US Commercial Services||US Market|
Return vs Industry: DSS underperformed the US Commercial Services industry which returned -6.3% over the past year.
Return vs Market: DSS underperformed the US Market which returned -20% over the past year.
|DSS Average Weekly Movement||7.9%|
|Commercial Services Industry Average Movement||7.0%|
|Market Average Movement||6.9%|
|10% most volatile stocks in US Market||15.5%|
|10% least volatile stocks in US Market||2.8%|
Stable Share Price: DSS is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: DSS's weekly volatility has decreased from 14% to 8% over the past year.
About the Company
DSS, Inc. operates in the product packaging, biotechnology, direct, commercial lending, securities and investment management, alternative trading, digital transformation, secure living, and alternative energy businesses worldwide. It manufactures, markets, and sells custom folding cartons, mailers, photo sleeves, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. The company also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases; and develops open-air defense initiatives for air-borne infectious diseases comprising tuberculosis and influenza.
DSS, Inc. Fundamentals Summary
|DSS fundamental statistics|
Is DSS overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|DSS income statement (TTM)|
|Cost of Revenue||US$24.04m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.24|
|Net Profit Margin||-93.65%|
How did DSS perform over the long term?See historical performance and comparison